These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 37995884

  • 1. Hepatic ChREBP orchestrates intrahepatic carbohydrate metabolism to limit hepatic glucose 6-phosphate and glycogen accumulation in a mouse model for acute Glycogen Storage Disease type Ib.
    Krishnamurthy KA, Rutten MGS, Hoogerland JA, van Dijk TH, Bos T, Koehorst M, de Vries MP, Kloosterhuis NJ, Havinga H, Schomakers BV, van Weeghel M, Wolters JC, Bakker BM, Oosterveer MH.
    Mol Metab; 2024 Jan; 79():101838. PubMed ID: 37995884
    [Abstract] [Full Text] [Related]

  • 2. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
    Lei Y, Hoogerland JA, Bloks VW, Bos T, Bleeker A, Wolters H, Wolters JC, Hijmans BS, van Dijk TH, Thomas R, van Weeghel M, Mithieux G, Houtkooper RH, de Bruin A, Rajas F, Kuipers F, Oosterveer MH.
    Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
    [Abstract] [Full Text] [Related]

  • 3. Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor α (LXRα) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1.
    Grefhorst A, Schreurs M, Oosterveer MH, Cortés VA, Havinga R, Herling AW, Reijngoud DJ, Groen AK, Kuipers F.
    Biochem J; 2010 Dec 01; 432(2):249-54. PubMed ID: 20854262
    [Abstract] [Full Text] [Related]

  • 4. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression.
    Dentin R, Pégorier JP, Benhamed F, Foufelle F, Ferré P, Fauveau V, Magnuson MA, Girard J, Postic C.
    J Biol Chem; 2004 May 07; 279(19):20314-26. PubMed ID: 14985368
    [Abstract] [Full Text] [Related]

  • 5. Glucose-6-phosphate-mediated activation of liver glycogen synthase plays a key role in hepatic glycogen synthesis.
    von Wilamowitz-Moellendorff A, Hunter RW, García-Rocha M, Kang L, López-Soldado I, Lantier L, Patel K, Peggie MW, Martínez-Pons C, Voss M, Calbó J, Cohen PT, Wasserman DH, Guinovart JJ, Sakamoto K.
    Diabetes; 2013 Dec 07; 62(12):4070-82. PubMed ID: 23990365
    [Abstract] [Full Text] [Related]

  • 6. Hepatic glucokinase regulatory protein and carbohydrate response element binding protein attenuation reduce de novo lipogenesis but do not mitigate intrahepatic triglyceride accumulation in Aldob deficiency.
    Buziau AM, Oosterveer MH, Wouters K, Bos T, Tolan DR, Agius L, Ford BE, Cassiman D, Stehouwer CDA, Schalkwijk CG, Brouwers MCGJ.
    Mol Metab; 2024 Sep 07; 87():101984. PubMed ID: 38972375
    [Abstract] [Full Text] [Related]

  • 7. Acute inhibition of hepatic glucose-6-phosphatase does not affect gluconeogenesis but directs gluconeogenic flux toward glycogen in fasted rats. A pharmacological study with the chlorogenic acid derivative S4048.
    van Dijk TH, van der Sluijs FH, Wiegman CH, Baller JF, Gustafson LA, Burger HJ, Herling AW, Kuipers F, Meijer AJ, Reijngoud DJ.
    J Biol Chem; 2001 Jul 13; 276(28):25727-35. PubMed ID: 11346646
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. LRH-1-dependent glucose sensing determines intermediary metabolism in liver.
    Oosterveer MH, Mataki C, Yamamoto H, Harach T, Moullan N, van Dijk TH, Ayuso E, Bosch F, Postic C, Groen AK, Auwerx J, Schoonjans K.
    J Clin Invest; 2012 Aug 13; 122(8):2817-26. PubMed ID: 22772466
    [Abstract] [Full Text] [Related]

  • 12. Dietary carbohydrate and control of hepatic gene expression: mechanistic links from ATP and phosphate ester homeostasis to the carbohydrate-response element-binding protein.
    Agius L.
    Proc Nutr Soc; 2016 Feb 13; 75(1):10-18. PubMed ID: 26264689
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hepatic glycogen cycling contributes to glucose lowering effects of the glucokinase activator LCZ960.
    Laurent D, Yerby B, Zhang B, Chen XH, Gounarides J, Zhang J, Gao J, Bebernitz G, Duttaroy A.
    Eur J Pharmacol; 2013 Sep 05; 715(1-3):89-95. PubMed ID: 23816435
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Liver ChREBP Protects Against Fructose-Induced Glycogenic Hepatotoxicity by Regulating L-Type Pyruvate Kinase.
    Shi JH, Lu JY, Chen HY, Wei CC, Xu X, Li H, Bai Q, Xia FZ, Lam SM, Zhang H, Shi YN, Cao D, Chen L, Shui G, Yang X, Lu Y, Chen YX, Zhang WJ.
    Diabetes; 2020 Apr 05; 69(4):591-602. PubMed ID: 31974143
    [Abstract] [Full Text] [Related]

  • 19. The role of glucose 6-phosphate in mediating the effects of glucokinase overexpression on hepatic glucose metabolism.
    Härndahl L, Schmoll D, Herling AW, Agius L.
    FEBS J; 2006 Jan 05; 273(2):336-46. PubMed ID: 16403021
    [Abstract] [Full Text] [Related]

  • 20. F6P/G6P-mediated ChREBP activation promotes the insulin resistance-driven hepatic lipid deposition in zebrafish.
    Gong Y, Lu Q, Xi L, Liu Y, Yang B, Su J, Liu H, Jin J, Zhang Z, Yang Y, Zhu X, Xie S, Han D.
    J Nutr Biochem; 2023 Dec 05; 122():109452. PubMed ID: 37748621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.